Psychodermatological disorders: Recognition and treatment

International Journal of Dermatology

Volumn 50, Issue 11, 2011, Pages 1309-1322

  Shenefelt, Philip D ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE; BOTULINUM TOXIN; CAPSAICIN; CITALOPRAM; CLOMIPRAMINE; DOXEPIN; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE MALEATE; GABAPENTIN; HALOPERIDOL; HYDROCORTISONE; HYPERICUM PERFORATUM EXTRACT; IMIPRAMINE; MENTHOL; NORTRIPTYLINE; OLANZAPINE; PAROXETINE; PIMOZIDE; PRAMOCAINE; PROTRIPTYLINE; RISPERIDONE; SERTRALINE; TRIMIPRAMINE; UNINDEXED DRUG; VENLAFAXINE;

ACNE; ACNE EXCORIEE; ALOPECIA; ANUS PRURITUS; ANXIETY DISORDER; BODY WEIGHT; BRACHIORADIAL PRURITUS; COGNITIVE BEHAVIORAL STRESS MANAGEMENT; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELUSION; DEPRESSION; DIABETES MELLITUS; DYSHIDROSIS; EMOTION; GLOSSODYNIA; HEART DISEASE; HEART DYSCONDUCTION; HERPES SIMPLEX; HUMAN; HYPERHIDROSIS; HYPERICUM PERFORATUM; IMPULSE CONTROL DISORDER; LICHEN PLANUS; LOW DRUG DOSE; MELANOMA; NEOPLASM; NEURODERMATITIS; NEUROTIC EXCORIATION; NONHUMAN; NOTALGIA PARASTHETICA; NUMMULAR DERMATITIS; OBSESSIVE COMPULSIVE DISORDER; ONYCHOTILLOMANIA; ORTHOSTATIC HYPOTENSION; PERIORAL DERMATITIS; POSTHERPETIC NEURALGIA; PRURITUS; PSORIASIS; PSYCHOGENIC PRURITUS; PSYCHOPHYSIOLOGY; PSYCHOSOMATIC DISORDER; RANDOMIZED CONTROLLED TRIAL; REVIEW; ROSACEA; SEBORRHEIC DERMATITIS; SEIZURE; SIDE EFFECT; SKIN DISEASE; SOMATOFORM DISORDER; TARDIVE DYSKINESIA; TELOGEN EFFLUVIUM; TRICHOTILLOMANIA; URTICARIA; VULVA PRURITUS;

BIOFEEDBACK, PSYCHOLOGY; COGNITIVE THERAPY; COMPLEMENTARY THERAPIES; HUMANS; MENTAL DISORDERS; PSYCHOPHYSIOLOGIC DISORDERS; PSYCHOTROPIC DRUGS; SKIN DISEASES;

EID: 80054776993     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2011.05096.x     Document Type: Review

References (101)

1. Zane LT. Psychoneuroendocrinimmunodermatology: pathophysiological mechanisms of stress in cutaneous disease. In: Koo JYM, Lee CS, eds. Psychocutaneous Medicine. New York: Marcel Dekker, 2003: 65-95.
2. Arck PC, Slominski A, Theoharides TC, et al. Neuroimmunology of stress: skin takes center stage. J Invest Dermatol 2006; 126: 1697-1704.
3. Fried RG. Nonpharmacologic treatments in psychodermatology. Dermatol Clin 2002; 20: 177-185.
4. Griesemer RD. Emotionally triggered disease in a dermatological practice. Psychiatr Ann 1978; 8: 49-56.
5. Urpe M, Buggiani G, Lotti T. Stress and psychoneuroimmunologic factors in dermatology. Dermatol Clin 2005; 23: 609-617.
6. Tausk F, Elenkov I, Moynihan J. Psychoneuroimmunology. Dermatol Ther 2008; 21: 22-31.
7. Shenefelt PD. Relaxation, meditation, and hypnosis for skin disorders and procedures. In: DeLuca BN, ed. Mind-Body and Relaxation Research Focus. Hauppauge, New York: Nova Science Publishers, 2008: 45-63.
8. Panconesi E. Psychosomatic factors in dermatology: special perspectives for application in clinical practice. Dermatol Clin 2005; 23: 629-633.
9. Seyhan M, Aki T, Karincaoglu Y, Ozcan H. Psychiatric morbidity in dermatology patients: frequency and results of consultations. Indian J Dermatol 2006; 51: 18-22.
10. Lee CS, Koo JYM. The use of psychotropic medications in dermatology. In: Koo JYM, Lee CS, eds. Psychocutaneous Medicine. New York: Marcel Dekker, 2003: 427-451.
11. Willemsen R, Roseeuw D, Vanderlinden J. Alexithymia and dermatology: the state of the art. Int J Dermatol 2008; 47: 903-910.
12. Picardi A, Porcelli P, Mazzotti E, et al. Alexithymia and global psychosocial functioning: a study on patients with skin disease. J Psychosom Res 2007; 62: 223-229.
13. Lucky AW. Quantitative documentation of a premenstrual flare of facial acne in adult women. Arch Dermatol 2004; 140: 423-424.
14. Hughes H, Brown BW, Lawlis GF, Fulton JE. Treatment of acne vulgaris by biofeedback relaxation and cognitive imagery. J Psychosom Res 1983; 27: 185-191.
15. Gupta MA, Gupta AK, Watteel GN. Stress and alopecia areata: a psychodermatologic study. Acta Derm Venereol 1997; 77: 296-298.
16. Willemsen R, Haentjens P, Roseeuw D, Vanderlinden J. Alexithymia in patients with alopecia areata: educational background much more important than traumatic events. J Eur Acad Dermatol Venereol 2009; 23: 1141-1146.
17. Willemsen R, Vanderlinden J, Deconinck A, Roseeuw D. Hypnotherapeutic management of alopecia areata. J Am Acad Dermatol 2006; 55: 233-237.
18. Pallanti S, Lotti T, Urpe M. Psychoneuroimmunodermatology of atopic dermatitis: from empiric data to the evolutionary hypothesis. Dermatol Clin 2005; 23: 695-701.
19. Stewart AC, Thomas SE. Hypnotherapy as a treatment for atopic dermatitis in adults and children. Br J Dermatol 1995; 132: 778-783.
20. Koblenzer CS. Dermatitis artifacta: clinical features and approaches to treatment. Am J Clin Dermatol 2000; 4: 161-163.
21. Koldys KW, Meyer RP. Biofeedback training in the therapy of dyshidrosis. Cutis 1979; 24: 219-221.
22. Buske-Kirchenbaum A, Geiben A, Wermke C, et al. Preliminary evidence for herpes labialis recurrence following experimentally induced disgust. Psychother Psychosom 2001; 70: 86-91.
23. Scott MJ. Hypnosis in Skin and Allergic Diseases. Springfield, Illinois: Charles C. Thomas, 1960.
24. Lowe NJ, Glaser DA, Eadie N, et al. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety. J Am Acad Dermatol 2007; 56: 604-611.
25. Hölzle E. Therapie der Hyperhidrosis. Hautarzt 1994; 35: 7-15.
26. Koray M, Dulger O, Ak G, et al. The evaluation of anxiety and salivary cortisol levels in patients with oral lichen planus. Oral Dis 2003; 9: 298-301.
27. Konuk N, Koca R, Atik L, et al. Psychopathology, depression and dissociative experiences in patients with lichen simplex chronicus. Gen Hosp Psychiatry 2007; 29: 232-235.
28. Lehman RE. Brief hypnotherapy of neurodermatitis: a case with four-year follow-up. Am J Clin Hypn 1978; 21: 48-51.
29. Jarvikallio A, Harvima IT, Naukkarinen A. Mast cells, nerves and neuropeptides in atopic dermatitis and nummular eczema. Arch Dermatol Res 2003; 295: 1-7.
30. Guarneri F, Marini H. An unusual case of perioral dermatitis: possible pathogenic role of neurogenic inflammation. J Eur Acad Dermatol Venereol 2007; 21: 410-412.
31. Arck P, Paus R. From the brain-skin connection: the neuroendocrine-immune misalliance of stress and itch. Neuroimmunomodulation 2006; 13: 347-356.
32. Griffiths CE, Richards HL. Psychological influence in psoriasis. Clin Exp Dermatol 2001; 26: 338-342.
33. Tausk F, Whitmore SE. A pilot study of hypnosis in the treatment of patients with psoriasis. Psychother Psychosom 1999; 68: 221-225.
34. Masmoudi J, Maalej I, Masmoudi A, et al. [Alexithymia and psoriasis: a case-control study of 53 patients] (in French). Encephale 2009; 35: 10-17.
35. Garnis-Jones S. Psychological aspects of rosacea. J Cutan Med Surg 1998; 2(Suppl. 4): 9-16.
36. Sinclair R. Chronic telogen effluvium: a study of 5 patients over 7years. J Am Acad Dermatol 2005; 52(2 Suppl 1): 12-16.
37. Barabasz M. Trichotillomania: a new treatment. Int J Clin Exp Hypn 1987; 35: 146-154.
38. Shertzer CL, Lookingbill DP. Effects of relaxation therapy and hypnotizability in chronic urticaria. Arch Dermatol 1987; 123: 913-916.
39. Inglese M, Haley HR, Elewski BE. Onychotillomania: 2 case reports. Cutis 2004; 73: 171-174.
40. Kearney CA, Silverman WK. Treatment of an adolescent with obsessive-compulsive disorder by alternating response prevention and cognitive therapy: an empirical analysis. J Behav Ther Exp Psychiatry 1990; 21: 39-47.
41. Mercan S, Altunay IK, Taskintuna N, et al. Atypical antipsychotic drugs in the treatment of delusional parasitosis. Int J Psychiatry Med 2007; 37: 29-37.
42. Gupta MA, Gupta AK. Depression and dermatological disorders. In: Koo JYM, Lee CS, eds. Psychocutaneous Medicine. New York: Marcel Dekker, 2003: 233-249.
43. Gupta MA. Somatization disorders in dermatology. Int Rev Psychiatry 2006; 18: 41-47.
44. Beck AT, Steer RA, Ball R, Ranieri W. Comparison of Beck Depression Inventories-IA and -II in psychiatric outpatients. J Pers Assess 1996; 67: 588-597.
45. Shenefelt PD. Using hypnosis to facilitate resolution of psychogenic excoriations in acne excoriée. Am J Clin Hypn 2004; 46: 239-245.
46. Gupta MA, Gupta AK, Haberman HF. Neurotic excoriations: a review and some new perspectives. Compr Psychiatry 1986; 27: 381-386.
47. Rothbaum BO, Ninan PT. Manual for the cognitive-behavioral treatment of trichotillomania. In: Stein DJ, Christenson GA, Hollander E, eds. Trichotillomania. Washington, DC: American Psychiatric Publishing, 1999: 263-284.
48. Stein DJ, Gardner JP, Keuthen NJ, et al. Trichotillomania, stereotypic movement disorder, and related disorders. Curr Psychiatry Rep 2007; 9: 301-302.
49. Rosenbaum MS, Ayllon T. The behavioral treatment of neurodermatitis through habit-reversal. Behav Res Ther 1981; 19: 313-318.
50. Kroenke K, Sharpe M, Sykes R. Revising the classification of somatoform disorders: key questions and preliminary recommendations. Psychosomatics 2007; 48: 277-285.
51. Bowe WP, Leyden JJ, Crerand CE, et al. Body dysmorphic disorder symptoms among patients with acne vulgaris. J Am Acad Dermatol 2007; 57: 222-239.
52. Klokk M, Stansfeld S, Overland S, et al. Somatization: the under-recognized factor in nonspecific eczema. The Hordaland Health Study (HUSK). Br J Dermatol 2011; 164: 593-601.
53. Henningsen P, Zipfel S, Herzog W. Management of functional somatic syndromes. Lancet 2007; 369: 1691-1692.
54. Harnack D, Scheel M, Mindt A, et al. Pregabalin in patients with antidepressant treatment-resistant somatiform disorders: a case series. J Clin Psychopharmacol 2007; 27: 537-539.
55. Weisshaar E, Kucenic MJ, Fleischer AB. Pruritus: a review. Acta Derm Venereol 2003; 213(Suppl.): 5-32.
56. Gupta MA, Gupta AK. Medically unexplained cutaneous sensory symptoms may represent somatoform dissociation: an empirical study. J Psychosom Res 2006; 60: 131-136.
57. Walcyk PJ, Elpern DJ. Brachioradial pruritus: a tropical dermopathy. Br J Dermatol 1986; 115: 177-180.
58. Goodkin R, Wingard E, Bernhard JD. Brachioradial pruritus: cervical spine disease and neurogenic/neurogenic pruritus. J Am Acad Dermatol 2003; 48: 521-524.
59. Gick CL, Mirowski GW, Kennedy JS, Bymaster FP. Treatment of glossodynia with olanzapine. J Am Acad Dermatol 2004; 51: 463-465.
60. Eisenberg E, Bameir E, Bergman R. Notalgia paraesthetica associated with nerve root impingement. J Am Acad Dermatol 1997; 37: 998-1000.
61. Eisenberg E, River Y, Shiftrin A, Krivoy N. Antiepileptic drugs in the treatment of neuropathic pain. Drugs 2007; 67: 1265-1289.
62. Cohen AD, Vander T, Medvendovsky E, et al. Neuropathic scrotal pruritus: anogenital pruritus is a symptom of lumbosacral radiculopathy. J Am Acad Dermatol 2005; 52: 61-66.
63. Weichert GE. An approach to the treatment of anogenital pruritus. Dermatol Ther 2004; 17: 129-133.
64. Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 593-602.
65. Picardi A, Abenia D, Melchi CF, et al. Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol 2000; 143: 983-991.
66. Sampogna F, Picardi A, Chren MM, et al. Association between poorer quality of life and psychiatric morbidity in patients with different dermatological conditions. Psychosom Med 2004; 66: 620-624.
67. Schulpis K, Georgala S, Papakonstantinou ED, et al. The psychological and sympatho-adrenal status in patients with cystic acne. J Eur Acad Dermatol Venereol 1999; 13: 24-27.
68. Hull PR, D'Arcy C. Acne, depression, and suicide. Dermatol Clin 2005; 23: 665-674.
69. Wysowski DK, Pitts M, Beitz J. An analysis of reports of depression and suicide in patients treated with isotretinoin. J Am Acad Dermatol 2001; 45: 515-519.
70. Gupta MA, Gupta AK, Schork NJ. Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria. Psychosom Med 1994; 56: 36-40.
71. Stoddard FJ, Stroud L, Murphy JM. Depression in children after recovery from severe burns. J Burn Care Rehabil 1992; 13: 340-347.
72. Herbert TB, Cohen S. Depression and immunity: a meta-analytic review. Psychol Bull 1993; 113: 472-486.
73. Shenefelt PD. Psychocutaneous hypnoanalysis: detection and deactivation of emotional and mental root factors in psychosomatic skin disorders. Am J Clin Hypn 2007; 50: 131-136.
74. Dogra S, Kanawar AJ. Skin diseases: psychological and social consequences. Indian J Dermatol 2002; 47: 197-201.
75. PDR Staff. 2009 Physician's Desk Reference, 63rd edn. Montvale, New Jersey: Thompson, 2009.
76. Kaplan HI, Saddock BJ. Kaplan and Sadock's Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry, 10th edn. Philadelphia, Pennsylvania: Lippincott Williams & Wilkins, 2007.
77. Warnock JK, Morris DW. Adverse cutaneous reactions to antidepressants. Am J Clin Dermatol 2002; 3: 329-339.
78. Warnock JK, Morris DW. Adverse cutaneous reactions to mood stabilizers. Am J Clin Dermatol 2003; 4: 21-30.
79. Navi D, Koo J. Safety update on commonly used psychotropic medications in dermatology. J Drugs Dermatol 2006; 2: 109-115.
80. Jafferany M. Psychodermatology: a guide to understanding common psychocutaneous disorders. Prim Care Companion J Clin Psychiatry 2007; 9: 203-213.
81. Jafferany M. Lithium and the skin: dermatologic manifestations of lithium therapy. Int J Dermatol 2008; 47: 1101-1111.
82. Bedi MK, Shenefelt PD. Herbal therapy in dermatology. Arch Dermatol 2002; 138: 232-242.
83. PDR Staff. 2009 PDR for Nonprescription Drugs, Dietary Supplements and Herbs, 30th edn. Montvale, New Jersey: Thompson, 2008.
84. Blumenthal M, ed. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin, Texas: American Botanical Council, 1998.
85. Kuribara H, Stavinoha WB, Maruyama Y. Behavioral characteristics of honkiol, an anxiolytic agent present in extracts of magnolia bark, evaluated by an elevated plus-maze test in mice. J Pharm Pharmacol 1998; 50: 819-826.
86. Linde K, Ramirez G, Mulrow C, et al. St Johns wort for depression: an overview and meta-analysis of randomized clinical trials. BMJ 1996; 313: 253-258.
87. Bressa G. S-adenosyl-L-methionine (SAMe) as antidepressant: meta-analysis of clinical studies. Acta Neurol Scand 1994; 154(Suppl.): 7-14.
88. Sarti MG. Biofeedback in dermatology. Clin Dermatol 1998; 16: 711-714.
89. Shenefelt PD. Biofeedback, cognitive-behavioral methods, and hypnosis in dermatology: is it all in your mind? Dermatol Ther 2003; 16: 114-122.
90. Levenson H, Persons JB, Pope KS. Behavior therapy & cognitive therapy. In: Goldman HH, ed. Review of General Psychiatry, 5th edn. New York: McGraw-Hill, 2000: 472.
91. Craig G. The EFT Manual. Santa Rosa, California: Energy Psychology Press, 2008.
92. Shapiro F. Eye Movement Desensitization and Reprocessing (EMDR): Basic Principles, Protocols, and Procedures, 2nd edn. New York, NY: Guilford Press, 2001.
93. Benor DJ, Ledger K, Toussaint L, et al. Pilot study of emotional freedom techniques, wholistic hybrid derived from eye movement desensitization and reprocessing and emotional freedom technique, and cognitive behavioral therapy for treatment of test anxiety in university students. Explore 2009; 5: 338-340.
94. Rainville P, Hofbauer RK, Bushnell MC, et al. Hypnosis modulates activity in brain structures involved in the regulation of consciousness. J Cogn Neurosci 2002; 14: 887-901.
95. Freeman R, Barabasz A, Barabasz M, Warner D. Hypnosis and distraction differ in their effects on cold pressor pain. Am J Clin Hypn 2000; 43: 137-148.
96. Shenefelt PD. Hypnosis in dermatology. Arch Dermatol 2000; 136: 393-399.
97. Shenefelt PD. Hypnoanalysis for dermatologic disorders. J Altern Med Res 2010; 2: 439-445.
98. Speigel D. Placebos in practice (editorial). BMJ 2004; 329: 927-928.
99. Di Blasi Z, Reilly D. Placebos in medicine: medical paradoxes need disentangling (letter). BMJ 2005; 330: 45.
100. Gupta MA, Gupta AK. Psychodermatology: an update. J Am Acad Dermatol 1996; 34: 1030-1046.
101. Ullman M. On the psyche and warts: I. Suggestion and warts: a review and comment. Psychosom Med 1959; 21: 473-488.